NT researchers discover breakthrough in malaria treatmentMarch 09, 2007An article published in the prestigious international journal 'The Lancet' by researchers from the Menzies School of Health Research (MSHR) in Darwin has revealed a breakthrough in the battle to treat Malaria - a disease which effects 40 per cent of the worlds population. There are two major strains of malaria effecting humans, P. vivax and P. falciparum. Although attention focuses on the more virulent P. falciparum, vivax malaria causes a huge amount of illness in the tropical countries of our region and puts many Australian travelers at risk of disease. Vivax malaria is becoming increasingly resistant to standard treatments, but few studies have determined the best way of treating it. In collaboration with partners at the Indonesian Ministry of Health, the MSHR team conducted a study in Papua, where they compared, head to head, two new treatments for malaria. Both contained a combination of drug based on a Chinese herbal extract (artemisinin) with a longer acting antimalarial drug.
The researchers found that both treatments provided initial cure from disease. However those receiving a treatment which stayed in the blood stream for longer were three times less likely to have another episode of malaria within 42 days and were less likely to be anaemic. MSHR scientist, Dr Ric Price, said that the findings have important implications for the treatment of malaria in our region and relevance to areas of Africa where the risk of malaria is greatest. "Scientists and doctors wage a constant battle to develop and implement effective treatments for malaria. This study is one of the first to highlight the best treatment of drug resistant strains of vivax malaria found in the Asia pacific region." said Dr Price. "It also provides evidence that longer acting drugs can prevent patients, who remain at risk of further infections, from getting sick again within 6 weeks. This "post treatment prophylaxis" is similar to the approach of giving travelers regular medication to protect them from infection, but can be applied opportunistically to people at high risk of infection in poor tropical communities." he added. A concern with such a policy is that the resistance will emerge quickly to the long acting drug. However the team believes that by combining the two drugs will help to prevent this from happening. Research Australia | |||||||||||||||||||||
|
Related Malaria Current Events and Malaria News Articles Dormant cancer cells rely on cellular self-cannibalization to survive A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation. Cell phones using lens-free imaging promise to improve health monitoring Cell phones have already revolutionized the way people around the world communicate and do business. Thanks to advances being made at UCLA, they are about to do the same thing for medicine. Case Western Reserve professor helps control infectious diseases with models and math Can an algebraic equation hold the secret to eradicating malaria or schistosomiasis? A Case Western Reserve University mathematics professor is utilizing the combination of algorithms and models in an effort to assist his medical colleagues in the fight against infectious diseases. NASA scientists report on new technology to help protect US troops from infectious diseases Representatives from NASA convened in New Orleans today to report at the American Society of Tropical Medicine and Hygiene Annual Meeting the results from a NASA-enhanced computerized system to assess environmental and health concerns for deployed U.S. forces. Promising trials of malaria vaccine lead to calls for Phase 3 development Experts are recommending that a malaria vaccine progress to Phase 3 trials following the successful trial of the RTS, S/AS01E malaria vaccine among 5-17 month old children in Korogwe, Tanzania and coastal Kenya, which is reported today in the New England Journal of Medicine (NEJM). Biomarkers in blood could aid diagnosis of crippling, often fatal forms of malaria Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Applying 'supply and demand' business principles to treat infectious diseases worldwide Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. 'Airport malaria' -- cause for concern in the US In a global world, significant factors affect the spread of infectious diseases, including international trade, air travel and globalized food production. "Airport malaria" is a term coined by researchers to explain the more recent spread of malaria to areas such as the United States and Europe, which some scientists credit to warmer climate changes. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||